Search for: "SANOFI-SYNTHELABO V. APOTEX, INC. "
Results 1 - 20
of 39
Sorted by Relevance
|
Sort by Date
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
9 Nov 2011, 9:59 pm
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative… [read post]
19 Jun 2007, 12:08 pm
Sanofi-Synthelabo v. [read post]
7 Nov 2008, 8:35 am
Sanofi-Synthelabo Canada Inc. [read post]
31 Aug 2006, 6:15 pm
Stein in Manhattan issued an injunction blocking the sale of generic Plavix ® (clopidogrel bisulfate) after a two-day hearing (Sanofi-Synthelabo v. [read post]
15 Aug 2006, 6:45 am
This is the court hearing the patent infringement suit, Sanofi-Synthelabo v. [read post]
19 Jun 2007, 9:45 pm
District Court for the Southern District of New York has issued a ruling in their favor in an infringement action against Apotex. [read post]
9 Nov 2017, 4:00 am
In that decision (Apotex Inc. v. [read post]
Three Strikes, You’re Out!? Apotex’s Latest Attempt to Invalidate the PLAVIX® Patent Denied by USPTO
9 Jul 2010, 3:00 am
Court of Appeals for the Federal Circuit (Sanofi-Synthelabo v. [read post]
19 Dec 2012, 8:51 pm
” Sanofi-Synthelabo v. [read post]
2 Nov 2009, 1:20 pm
’s judgment for the Court in Apotex Inc. v. [read post]
23 Mar 2009, 7:34 am
Apotex, Inc. after the jump. [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer)… [read post]
2 Nov 2010, 1:40 am
Genentech, Inc. v. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) –… [read post]
4 Nov 2010, 6:14 am
” Golden Blount, Inc. v. [read post]
18 Feb 2011, 11:47 am
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
15 Dec 2008, 5:34 am
Sanofi-Synthelabo v. [read post]
24 Dec 2008, 3:00 pm
Apotex, Inc (Managing Intellectual Property) [read post]
25 Jun 2007, 2:10 am
Apotex Inc. [read post]
